Aberrant Immune activation in the tuberculous granuloma: a pivotal role in necrosis07/15/2016 - 06/30/2020 (PI)
NIH/National Heart, Lung, and Blood Institute1R01HL133190-01
Necrosis in Pulmonary TB granulomas: dynamics, mechanisms, therapies05/01/2016 - 04/30/2020 (PI)
NIH/National Heart, Lung, and Blood Institute1R01HL126066-01A1
Novel TB Treatment Strategy - Optimization of Macrophage Responsiveness to IFNy03/11/2015 - 02/28/2019 (PI)
NIH/National Institute of Allergy & Infectious Diseases5R33AI105944-05
Genetic-based susceptibility to pulmonary tuberculosis04/15/2015 - 03/31/2018 (PI)
Trustees of Tufts College, Inc NIH NIAID5R21AI115038-02
Novel TB Treatment Strategy- Optimization of Macrophage Responsiveness to IFNy03/01/2013 - 02/28/2015 (PI)
NIH/National Institute of Allergy & Infectious Diseases5R21AI105944-02
Genetics of Host Resistance and Susceptibility to MTB08/01/2012 - 07/31/2014 (PI)
NIH/National Heart, Lung, and Blood Institute7R01HL059836-16
Macrophage Genomic ‘Barcodes’ for Rapid Identification of Pathogens and Therapeutic Targets09/17/2010 - 05/31/2013 (PI)
Harvard School of Public Health DOD Threat Reduction
MACROPHAGE GENOMIC 'BARCODES' FOR RAPID IDENTIFICATION OF PATHOGENS AND THERAPEUTIC TARGETS09/17/2010 - 05/31/2013 (PI)
Harvard School of Public Health DOD DARPA
Genetics of Host resistance & susceptibility to MTB08/01/2009 - 08/02/2012 (PI)
NIH-NHLBI5R01 HL059836-15